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Disruption of APOL1-miR193a 
Axis Induces Disorganization of 
podocyte Actin Cytoskeleton
Vinod Kumar1, Nitpriya Paliwal1, Kamesh Ayasolla1, Himanshu Vashistha2, Alok Jha1, 
Nirupama Chandel1, Sheetal Chowdhary1, Moin A. Saleem3, Ashwani Malhotra1, 
Praveen N. Chander4, Karl skorecki5 & Pravin C. Singhal1
APOL1-miR193a axis participates in the preservation of molecular phenotype of differentiated 
podocytes (DPDs). We examined the hypothesis that APOL1 (G0) preserves, but APOL1 risk alleles 
(G1 and G2) disrupt APOL1-miR193a axis in DPDs. DPDG0s displayed down-regulation of miR193a, 
but upregulation of nephrin expression. DPDG1s/G2s exhibited an increase in miR193a and down-
regulation of the expression of adherens complex’s constituents (CD2AP, nephrin, and dendrin). 
DPDG0s showed decreased Cathepsin L, enhanced dynamin expressions, and the intact actin 
cytoskeleton. On the contrary, DPDG1s/G2s displayed an increase in Cathepsin L, but down-regulation 
of dynamin expressions and disorganization of the actin cytoskeleton. APOL1 silencing enhanced 
miR193a and Cathepsin L, but down-regulated dynamin expressions. DPDG1s/G2s displayed nuclear 
import of dendrin, indicating an occurrence of destabilization of adherens complexes in APOL1 risk 
milieu. These findings suggest that DPDG1s and DPDG2s developed disorganized actin cytoskeleton 
as a consequence of disrupted APOL1-miR193a axis. Interestingly, docking and co-labeling studies 
suggested an interaction between APOL1 and CD2AP. APOL1G1/G1 and APOL1G1/G2 transgenic mice 
displayed nuclear import of dendrin indicating destabilization of adherens complexes in podocytes; 
moreover, these mice showed a four-fold increase in urinary albumin to creatinine ratio and 
development of focal segmental glomerular lesions.
African Americans carrying APOL1 renal risk alleles have been reported to develop chronic kidney disease (s) at 
a several-fold higher rate when compared to European Americans1–3. We and others have reported observations 
in multiple experimental platforms, which is consistent with the premise that it is a consequence of gain of injury 
from cytotoxic effects of overexpressing APOL1 risk alleles4–15. This formulation is also consistent with the appar-
ent dispensability of APOL1 for podocyte and kidney health in many species10,11. On the other hand, a recessive 
inheritance mode for kidney disease risk in association with the APOL1 risk alleles in genetic epidemiologic 
studies is more consistent with a loss rather than a gain of function by APOL1 risk alleles16–18. Recently, we have 
reported that APOL1 wild-type (G0) preserves the podocyte molecular phenotype in adverse milieus associated 
with enhanced miR193a levels19. We now hypothesize that APOL1-miR193a axis preserves the integrity of the 
actin cytoskeleton in differentiated podocytes through stabilization of the adherens complex (AC), while disrup-
tion of APOL1-miR193a axis in podocytes expressing APOL1 risk alleles induces loss of this function.
Optimal expression of the AC proteins is considered to be an integral part of podocyte health20,21. Nephrin is 
one of the most important constituents of the ACs and is transcribed by Wilms tumor type (WT) 1 transcription 
factor20,22. Since miR193a inversely regulates the expression of WT1, it also inversely regulates the transcription 
of nephrin in podocytes19,22,23. A decrease in nephrin expression disintegrated the ACs and resulted in nuclear 
import of dendrin, followed by the activation of a pro-apoptotic pathway24. In Danio rerio (Zebrafish), silencing 
of its endogenous APOL1 contributed to altered expression of nephrin in nephrocytes as well as in the develop-
ment of a dysfunctional glomerular filtration barrier25. These investigators suggested a role of Zebrafish APOL1 
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in the maintenance of the glomerular filtration barrier. However, its participation in the stability of ACs was 
not investigated in this model. On the other hand, an overexpression in Zebrafish pro-nephrons of exogenous 
human APOL1 non-risk and risk variants did not fully recapitulate a Zebrafish phenotype consistent with human 
APOL1 renal risk nephropathy under Puromycin Aminonucleoside (PAN) challenge26. We are hypothesizing that 
enhanced miR193a expression resulting as a consequence of mutation in the APOL1 gene destabilizes the ACs 
through decreased nephrin expression.
The nuclear dendrin transcribes Cathepsin (CTS) L27, which promotes the degradation of synaptopodin, 
CD2AP, and dynamin through its proteolytic activity in podocytes27. Optimal expression of synaptopodin 
and dynamin is essential for the maintenance of the integrity of the podocyte actin cytoskeleton27. Therefore, a 
decrease in any of the constituents of the ACs could destabilize the complex and induce disorganization of the 
actin cytoskeleton in podocytes27. The role of CD2AP in the maintenance of the ACs has been studied in the past27. 
CD2AP-deficient mice developed massive proteinuria and nephrotic syndrome at approximately four weeks of 
age and succumbed to renal failure at 6–10 weeks of age28. Since the kidney phenotype of CD2AP-deficient ani-
mals could be rescued with a podocyte-specific expression of CD2AP, it has been suggested that the kidney dys-
function would be a consequence of the loss of CD2AP in the podocytes29.
PH-dependent ion selectivity has been attributed for APOL1’s effects in both the endosomal and the plasma 
membranes. Endosomal acidification initiates exogenous APOL1’s insertion in the membrane contributing to 
anion-selective permeability; the latter is responsible for APOL1’s pleiotropic effects in intracellular compart-
ments30. Although the endogenous APOL1 is also inserted in the membranes of acidified exocytic vesicles tar-
geted to the plasma membrane, however, it inhibits anion permeability at neutral pH of the plasma membrane14,31. 
Since APOL1 is also a plasma membrane protein, it carries a potential to interact with the AC constituents.
In the present study, we have examined the role of APOL1– miR193a axis in the maintenance of stability of 
the ACs and the integrity of actin cytoskeleton in human differentiated podocytes. Also, we have evaluated the 
effects of disruption of APOL1-mIR193a axis on the stability of the ACs and the organization of actin filaments in 
podocytes expressing APOL1 risk alleles. We used interventions which resolved the defective signaling in adverse 
milieus and podocytes expressing APOL1 risk alleles.
Results
Evaluation whether APOL1 and Nephrin preserve the stability of adherens complexes (ACs). 
To evaluate whether lack of either APOL1 or nephrin in DPDs would disrupt the complex equally and result in 
enhanced CTSL expression, DPDS were transfected with either scrambled (SCR), APOL1- or nephrin-siRNAs 
(n = 10). Protein blots of control (C), DPD-transfected with SCR/siRNA nephrin/siRNA APOL1 were probed for 
CD2AP, nephrin, APOL1, dendrin, and CTSL. The same blots were reprobed for GAPDH. Gels from three differ-
ent cellular lysates are shown in Fig. 1A. Cumulative densitometric data for each variable are shown as dot plots 
(Fig. 1B–F). DPDs silenced for either APOL1 or nephrin displayed attenuated expression of CD2AP (Fig. 1A and D) 
but enhanced expression of CTSL (Fig. 1A and E). These findings suggest that both nephrin and APOL1 are 
required to maintain the stability of the ACs in human DPDs.
Evaluation of the relationship between APOL1 and AC constituents. We hypothesized that if 
silencing of APOL1 destabilizes the complex, then overexpression of APOL1 would enhance the stabilization of the 
AC further. PDs-stably expressing vector (PDV) and APOL1G0 (PDG0) were differentiated for ten days and then 
transfected with either scrambled or APOL1 siRNA (n = 5). Protein blots were probed for APOL1, CD2AP, CTSL, 
and dynamin and reprobed for GAPDH. The same lysates were reprobed for nephrin, dendrin, and GAPDH. 
Gels from two different lysates are displayed in Fig. 2A and B). Densitometric data for each variable are shown as 
dot plots (Fig. 2C–H). Silencing of APOL1 (Fig. 2A and C) decreased the expression of CD2AP (Fig. 2A and D) 
and dynamin (Fig. 2A and E) but increased the expression of CTSL (Fig. 2A and E). On the other hand, DPDG0 
displayed enhanced expression of CD2AP (Fig. 2A and D) and minimal expression of CTSL (Fig. 2A and E). 
Conversely, silencing of APOL1 decreased the expression of nephrin in both Vector and APOL1G0 expressing 
podocytes (Fig. 2B and G). These findings indicate that lack of APOL1 downregulates the expression of AC con-
stituents, but the presence of APOL1 increases their expressions.
Evaluation of the relationship between APOL1 and CD2AP. We next asked whether APOL1 has an 
interaction with any of the constituents of ACs. To determine APOL1’s link with CD2AP, undifferentiated and 
differentiated APOL1G0 expressing Podocytes were grown on coverslips. Podocytes were co-labeled for APOL1 
and CD2AP and examined under a confocal microscope. Representative fluoromicrographs are shown in Fig. 3A. 
Both APOL1 and CD2AP showed partial co-labeling at adherens junctions of podocytes.
Protein-protein Interaction (PPI) Interface analyses of APOL1G0 and CD2AP. To evaluate 
protein-protein interaction between APOL1 and CD2AP, we have carried out bioinformatics analysis32. The 
details are described in supplementary data (S.Fig. 3B). The CD2AP binds to the APOL1 in the carboxy-terminal 
region and residues from Membrane Addressing Domain (MAD) of APOL1 are also interacting with residues of 
CD2AP (Fig. 3B).
APOL1G0 and miR193a interactions. Since APOL1 forms an axis with miR193a, we have carried out 
bioinformatics analysis to evaluate binding sites. The details are described in supplementary data (S. Fig. 3C). The 
residues of miR193a that correspond to the miR193a binding site at the 3′UTR region of the APOL1 mRNA (36)  
are displayed symbolically on protein surface (Fig. 3C). Also, there are seven hydrogen bonds in the interface of 
APOL1G0 and miR193a complex.
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APOL1 risk alleles destabilize the ACs. To determine the role of APOL1G0 and APOL1 risk alleles in sus-
taining the stability of the adherens complex, protein blots of DPDs-stably over-expressing Vector (V), APOL1G0, 
APOL1G1, and APOL1G2 were probed for APOL1, nephrin, CD2AP, and dynamin. Representative gels are dis-
played in Fig. 4A and B. Cumulative densitometric data on each variable are shown as dot plots (Fig. 4C–H). 
DPDG0s displayed higher expressions of nephrin, CD2AP, and dynamin but lower expression of CTSL when 
compared to DPDG1s and DPDG2s (Fig. 4A–G). These findings suggest that there is destabilization of the ACs 
in DPDs expressing APOL1 risk alleles.
Moreover, an increase in CTSL generation by DPDs expressing APOL1G1 and APOL1G2 suggested the 
nuclear import of dendrin in these cells. To confirm the nuclear localization of dendrin, DPDs expressing vec-
tor, G0, G1, and G2 (grown on coverslips) were labeled for dendrin. Nuclei were stained with DAPI. Cells were 
imaged under a confocal microscope. Representative fluoromicrographs are shown in Fig. 4I. DPDs expressing 
vector and G0 displayed predominant labeling for dendrin in the cytosol, whereas, DPDs expressing G1 and G2 
displayed significant nuclear localization of dendrin (Fig. 4I).
Figure 1. Evaluation of the effects of lack of APOL1 and Nephrin on the stability of adherens complex. (A) 
DPDS were transfected with either scrambled (SCR), APOL1- or nephrin-siRNAs (n = 10). Protein blots of 
control (C), DPD-transfected with SCR/SiRNA nephrin/siRNA APOL1 were probed for CD2AP, nephrin, 
APOL1, dendrin, and CTSL (n = 10). The same blots were reprobed for GAPDH. Gels from three different 
cellular lysates are displayed. (B–F) Cumulative densitometric data for each variable (protein/GAPDH) are 
shown as dot plots. ***p < 0.001 vs respective control and SCR; ###p < 0.001 vs. respective control and SCR. For 
clarity lanes were cropped from different gels. Full-length blots are presented in Fig. S1.
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To determine the effect of APOL1 risk alleles on the DPDs’ expression of dynamin and the integrity of actin 
cytoskeleton, DPDs expressing vector, G0, G1, and G2 (grown on coverslips) were co-labeled for F-actin (by 
phalloidin) and dynamin (n = 3). Nuclei were stained with DAPI. Cells were examined under a fluorescence 
microscope. Representative fluoromicrographs are shown in Fig. 4J. DPDs expressing vector and G0 displayed 
well- spread and intact actin filaments. On the other hand, DPDs expressing G1 and G2 displayed predominantly 
cortical labeling for F-actin and a decreased number of actin filaments. Similarly, DPDs expressing vector and G0 
displayed moderate expression of dynamin. However, DPDs expressing G1 and G2 displayed minimal expres-
sion of dynamin. Accumulation of F-actin at the cortices of phalloidin labeled cells in vector- and APOL1G0-, 
APOLG1-, and APOL1G2-expressing cells were graded in the form of cortical F-actin score index. Cumulative 
data is shown in a bar diagram (Fig. 4K). DPDs expressing APOL1G1 and APOL1G2 displayed a higher (P < 0.01) 
cortical actin score when compared to DPDs expressing Vector or APOL1G0.
APOL1G0 binds with one of the constituents of the ACs, but APOL1 risk alleles lack this property. 
To evaluate whether constituents of the ACs are present in DPDV (DPDs-stably expressing vector) and DPDG0 
(DPDs-stably expressing ectopic APOL1G0), cellular lysates of DPDVs and DPDG0s were probed for APOL1, 
CD2AP, dendrin, nephrin and reprobed for GAPDH (n = 3). Gels from three different lysates are displayed in 
Fig. 5A. Densitometric data are shown in Fig. 5B. DPDG0 displayed enhanced expression of APOL1, CD2AP, 
dendrin, and nephrin when compared to DPDVs.
To determine the binding status, cellular lysates of DPDVs and DPDG0s were immunoprecipitated (IP) with 
an anti-APOL1 antibody (n = 3). IP fractions were probed for APOL1, CD2AP, dendrin, nephrin, and IgG. Gels 
Figure 2. Effect of Ectopic overexpression or silencing of APOL1 on the stability of adherens complexes. (A) 
PDs stably expressing vector (PDV) and ectopic APOL1G0 (PDG0) were differentiated for ten days and the 
transfected with either scrambled or APOL1 siRNA (n = 5). Protein blots were probed for APOL1, CD2AP, 
CTSL, and dynamin and reprobed for GAPDH. The Gels from two different lysates are displayed. (B) Protein 
blots from the above lysates were probed for nephrin and dendrin and reprobed for GAPDH. The gels from two 
different lysates are shown. (C–H) Densitometric data for each variable (protein/GAPDH) are shown as dot 
plots. (C) *P < 0.05 compared with V/SCR; ***P < 0.001 compared with V/SCR; ###P < 0.001 compared with 
G0/SCR. (D) **P < 0.01 compared with V/SCR; ###P < 0.001 compared with G0/SCR. (E) *P < 0.0.5 compared 
with V/SCR; **P < 0.01 compared with V/SCR; ###P < 0.001 compared with G0/SCR. (F) *P < 0.05 compared 
with V/SCR; **P < 0.01 compared with V/SCR; ###P < 0.001 compared with G0/SCR. (G) **P < 0.0a compared 
with V/SCR; ###P < 0.001 compared with G0/SCR. For clarity lanes were cropped from different gels. Full-length 
blots are presented in Fig. S2.
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from three different fractions are displayed in Fig. 5C. Densitometric data is shown in Fig. 5D. IP fractions of 
DPDG0 displayed enhanced expression of APOL1, CD2AP, dendrin, and nephrin. These findings suggest that 
APOL1 binds with CD2AP along with other constituents of the ACs.
To determine the status of APOL1 binding in DPDs expressing APOL1 risk alleles, cellular lysates of DPDVs, 
DPDG0s, DPDG1s, and DPDG2s were probed for APOL1, nephrin, CD2AP, dendrin, and GAPDH (n = 3). 
Gels from three different lysates are displayed in Fig. 5E. Densitometric data are shown in Fig. 5F. DPDG1s and 
DPDG2s displayed decreased expression of nephrin, CD2AP, and dendrin when compared to DPDG0s. These 
findings suggest destabilization of ACs in DPDs expressing APOL1 risk alleles.
To substantiate this, the above-mentioned cellular lysates were immunoprecipitated with an anti-CD2AP 
antibody. IP fractions from different lysates were probed for the constituents of the ACs and IgG. Gels from 
three different IP fractions have been shown in Fig. 5G. Cumulative densitometric data are shown in bar graphs 
(Fig. 5H). DPDG0s displayed a higher expression for APOL1, nephrin, CD2AP, and dendrin when compared to 
DPDG1s and DPDG2s. These findings confirm the occurrence of the destabilization of the complexes in DPDs 
expressing G1 and G2.
To exclude the non-specific binding of IgG to APOL1 or CD2AP, lysates of DPDV, DPDG0, DPDG1, and 
DPDG2 were immunoprecipitated with non-immune IgG. IP fractions were probed for APOL1, CD2AP, den-
drin, and IgG. Gels from three different lysates are shown in Fig. 5I.
APOL1 risk alleles induce disruption in the APOL1-miR193 axis. We asked whether DPD-expressing 
APOL1 risk alleles carry an intact APOL1-miR193a axis. To confirm the status of APOL1-miR193a axis 
in DPDs-stably expressing vector, G0, G1, and G2, RNAs were extracted and assayed for miR193a (n = 3). 
Cumulative data are shown in bar graphs in Fig. 6A. DPDs expressing G0 down-regulated the expression of 
miR193 by 50% when compared to DPDs expressing vector. However, DPDs expressing G1 and G2 showed 
upregulation (two-fold) of miR193a. These findings indicate that an intact (functional) APOL1-miR193a axis in 
DPDs requires the expression of non-risk APOL1.
Since miR193a inversely regulates the expression of WT122, a transcription factor for the expression of 
nephrin, disruption of APOL1-miR193a axis would result in suboptimal transcription of nephrin in DPDs 
Figure 3. An interaction between APOL1 and CD2AP at the plasma membrane. (A) Undifferentiated 
and differentiated PDG0 grown on coverslips were co-labeled for APOL1 and CD2AP. Representative 
fluoromicrographs are shown. Undifferentiated PDs displayed scattered labeling for APOL1 (red fluorescence) 
and CD2AP (green fluorescence). Differentiated PD showed co-labeling for APOL1 and CD2AP (yellow 
fluorescence, indicated by white arrows) at adherent junctions. Horizontal solid white bar represents the scale 
as 100 µm. (B) The CD2AP binds to the APOL1 in the carboxy-terminal region and residues from Membrane 
Addressing Domain (MAD) of APOL1 are also interacting with residues of CD2AP. Hotspot residues in the 
protein-protein interaction interface of APOL1G0 (Raspberry) and CD2AP (Warm pink). (C) The interaction 
interface of APOL1G0 and miR193a has a total interface area of 1339.1 Å2 and the solvation free energy gain 
upon formation of interface ΔiG is −34.3 kcal/mol. The solvation free energy of folding for the corresponding 
structure ΔG is −263.1 kcal/mol. The hotspot residues (magenta) in the miRNA-Protein interaction interface 
of APOL1G0 and miR193a. The 5′ end of miR193a binds to the 3′ UTR region of APOL1G0 mRNA (36) and 
displayed symbolically on protein surface.
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expressing APOL1G1 and APOL1G2. To validate our notion, protein blots of DPDs expressing vector, G0, 
G1, and G2 were probed for nephrin and reprobed for GAPDH (n = 3). Gels from two different lysates are dis-
played in Fig. 6B (upper panel). DPDs expressing APOL1 risk alleles showed a decreased expression of nephrin. 
Cumulative densitometric data are shown as bar graphs (Fig. 6B, lower panel).
Figure 4. APOL1 risk alleles destabilize the adherens complex. (A) Protein blots of DPDs stably over-
expressing Vector (V), G0, G1, and G2 were probed for APOL1, nephrin, CD2AP, dynamin, CTSL, and GAPDH 
(n = 5–7). Representative gels are displayed. (B) Protein blots of the above lysates were probed for dendrin 
and reprobed for GAPDH (n = 5). (C–H) Cumulative densitometric data on each variable (protein/GAPDH) 
are shown as dot plots. *<0.05 compared with respective V; **P < 0.01 compared with respective V; †P < 0.05 
compared with respective G0; ‡P < 0.01 compared with respective G1 and G2. (I) PDs expressing vector, G0, 
G1, and G2 grown on coverslips were differentiated and labeled for dendrin (n = 3). Nuclei were stained with 
DAPI. Cells were imaged under a confocal microscope. Representative fluoromicrographs are displayed. 
DPDs expressing vector and G0 showed predominantly cytosolic dendrin (indicated by green fluorescence). 
However, DPD expressing G0 and G1 showed predominantly nuclear localization of dendrin. Horizontal solid 
white bar represents the scale as 100 µM. (J) PDs expressing vector, G0, G1, and G2 grown on coverslips were 
differentiated (n = 3). Subsequently, cells were co-labeled for F-actin (by phalloidin) and dynamin. Nuclei 
were stained with DAPI. Cells were examined under a confocal microscope. Representative fluoromicrographs 
are shown. DPDs expressing vector and G0 displayed well- spread and intact actin filaments (indicated by 
red fluorescence). DPDs expressing G1 and G2 displayed predominantly cortical labeling for F-actin. DPDs 
expressing vector and G0 displayed moderate expression of dynamin (indicated by green fluorescence). DPDs 
expressing G1 and G2 displayed minimal expression of dynamin. Horizontal solid white bar represents the scale 
as 50 µm. (K) The cortical F-actin score (CFS) index was calculated under control and experimental conditions. 
DPDAPOLG1 (G1) and DPDAPOL1G2 (G2) displayed an increased CFS index compared with DPDV (Vector) 
and DPDAPOL1G0 (G0). ***P < 0.001 compared with V and G0; ###P < 0.001 compared to V and G0. For 
clarity lanes were cropped from different gels. Full-length blots are presented in Fig. S4.
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We asked if APOL1 risk alleles are inducing destabilization of ACs as a consequence of the upregulation 
of miR193a expression. If so then a higher level of miR193a de novo would down-regulate WT1, nephrin, and 
CD2AP in DPDs. To validate the role of the miR193a-APOL1 axis, DPDs were transfected with either empty 
(EV) vector or miR193a plasmid. Protein blots of control and experimental DPDs (transfected with either EV 
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Figure 5. APOL1 binds with one of the constituents of adherens complex. (A) Cellular lysates of DPDVs 
(DPDs expressing vector) and DPDG0s (DPDs expressing APOL1 G0) were probed for APOL1, CD2AP, 
dendrin, nephrin, and reprobed for actin (n = 3). Gels from three different lysates are displayed. (B) Cumulative 
densitometric data from protein blots displayed in 5A. **P < 0.01 compared with respective vector variables. 
(C) The cellular lysates of DPDVs and DPDG0s in the 5A were immunoprecipitated (IP) with an anti-APOL1 
antibody (n = 3). IP fractions were probed for APOL1, CD2AP, dendrin, nephrin, and IgG. Gels from three 
different fractions are displayed. (D) Cumulative densitometric data from protein blots displayed in 5C. **P < 0.01 
compared to respective Vec. (E) The cellular lysates of DPDVs, DPDG0s, DPDG1s, and DPDG2s were probed for 
APOL1, nephrin, CD2AP, CTSL, dynamin, and GAPDH (n = 3). Gels from three different lysates are displayed. 
(F) Cumulative densitometric data from protein blots displayed in 5E. *P < 0.05 compared to respective Vec, G1, 
and G2. (G) The cellular lysates in the 5E were immunoprecipitated with an anti-CD2AP antibody. IP fractions of 
three different lysates were probed for APOL1, CD2AP, dendrin, nephrin, and IgG. Gels from there different IP 
fractions have been displayed. (H) Cumulative densitometric data from protein blots displayed in 5G. *P < 0.05 
compared to respective Vec, G1, and G2. (I) The cellular lysates of DPDVs, DPDG0s, DPDG1s, and DPDG2s in 
the 5E were immunoprecipitated (IP) with a non-specific mouse IgG (n = 3). IP fractions were probed for APOL1, 
CD2AP, dendrin, nephrin, and IgG. Gels from three different fractions are displayed. For clarity lanes were 
cropped from different gels. Full-length blots are presented in Fig. S5.
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or miR193a plasmid) were probed for APOL1, WT1, nephrin, CD2AP and reprobed for GAPDH. The same 
lysates were reprobed for CTSL, dynamin, and GAPDH. Gels from three different lysates are shown in Fig. 6C 
and D. Cumulative densitometric data are shown in bar graphs (Fig. 6E and F). An overexpression of miR193a in 
DPDs, downregulated APOL1, WT1, nephrin, CD2AP, dynamin, but upregulated the expression of CTSL. These 
findings suggest that APOL1 risk alleles down-regulate the expression of at least one of the constituents of ACs 
through disruption of the APOL1-miR193a axis.
Vitamin D receptor agonist (VDA) down-regulates miR193a and modulates APOL1 risk 
alleles-induced downstream signaling. To determine whether VDA would be able to resolve APOL1 risk 
alleles-induced disruption of the APOL1-miR193a axis, DPDVs, DPDG0s, DPDG1s, and DPDG2s were incu-
bated in media containing either vehicle (DMSO) or VDA (EB1089, 10 nM) for 48 hours. RNAs were extracted 
and assayed for miR193a (n = 3). Cumulative data are shown in bar graphs (Fig. 7A). In DPDG0, expression of 
miR193a was down-regulated while in DPDG1 and DPDG2, it was enhanced. VDA down-regulated miR193a 
expression in DPDV, DPDG0s, DPDG1s, and DPDG2s by several folds when compared to respective controls.
To determine the effect of VDA on the transcription of APOL1, WT1, CD2AP, and CTSL, RNAs were extracted 
from DPDVs, DPDG0s, DPDG1s, and DPDG2s. cDNAs were amplified with specific primers for APOL1, WT1, 
CD2AP, and CTSL (n = 3). Cumulative data are shown in bar graphs in Fig. 7B. VDA enhanced the transcription 
of APOL1, and CD2AP, but decreased the transcription of CTSL in DPDVs, DPDG0s, DPDG1s, and DPDG2s.
VDA down-regulates Puromycin aminonucleoside (PAN)-induced DPD expression of miR193a. 
PAN is known for its podocyte cytotoxicity5,20. We asked whether PAN enhances DPDs’ expression of miR193a; 
if yes, whether VDA or miR193a inhibitor would be able to down-regulate PAN-induced miR193a expression. 
To determine the effect of VDA and a miR193a inhibitor on PAN-induced miR193a expression, DPDs were 
transfected with either empty vector (EV) or miR193a inhibitor (plasmid, 25 nM), or treated with VDA (EB1089, 
10 nM) in the presence or absence of PAN (30 ng/ml) for 48 hours (n = 3). RNAs were extracted and assayed for 
miR193a. Cumulative data are shown in bar graphs (Fig. 8A). PAN enhanced DPDs’ expression of miR193a by 2.5 
fold. Both miR193a inhibitor and VDA down-regulated (P < 0.05) DPDs’ expression of miR193a in PAN milieu.
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Figure 6. APOL1 risk alleles induce disruption in APOL1-miR193a axis. (A) RNAs were extracted from 
DPDs expressing vector, G0, G1, and G2 (n = 3). RNAs were assayed for miR193a. Cumulative data are shown 
in bar graphs. *P < 0.05 compared with V; **P < 0.01 compared with all other variables. (B) Protein blots of 
DPDs expressing vector, G0, G1, and G2 were probed for nephrin and reprobed for actin (n = 3). Gels from 
two different lysates are displayed in the upper panel. Cumulative densitometric data are shown as bar graphs 
in the lower panel. *P < 0.05 compared with V; **P < 0.01 compared with all other variables. (C) DPDs were 
transfected with either empty vector (25 nM, EV) or mir193a plasmid (25 nM). Protein blots of control and 
experimental DPDs (transfected with either EV or miR193a plasmid) were probed for APOL1, WT1, nephrin, 
CD2AP and reprobed for GAPDH. Gels from three different lysates are shown. (D) The lysates in 6C were probed 
for CTSL and dynamin and reprobed for GAPDH. Gels from three different lysates are shown. (E) Cumulative 
densitometric data (from 6C) are shown in bar graphs. **P < 0.01 compared with respective control and EV; 
***P < 0.001 compared with respective control and EV. (F) Cumulative densitometric data (from D) are shown 
in bar graphs. **P < 0.01 compared with respective control and EV; ***P < 0.001 compared with respective 
control and EV. For clarity lanes were cropped from different gels. Full-length blots are presented in Fig. S6.
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Figure 7. Vitamin D receptor agonist (VDA) down-regulates miR193a and modulates APOL1 risk-induced 
downstream signaling. (A) DPDVs (VEC), DPDG0s (G0), DPDG1s (G1), and DPDG2s (G2) were incubated 
in media containing either vehicle (DMSO) or VDA (EB1089, 10 nM) for 48 hours. RNAs were extracted and 
assayed for miR193a (n = 3). Cumulative data are shown in bar graphs. #P < 0.05 compared VEC; ##P < 0.01 
compared with VEC and G0. *P < 0.05 compared with untreated VEC and G0; **P < 0.01 compared with 
untreated G1 and G2. (B) RNAs were extracted from DPDVs (V), DPDG0s (G0), DPDG1 (G1), and DPDG2s 
(G2) and cDNAs were amplified with specific primers for APOL1, WT1, CD2AP, and CTSL (n = 3). Cumulative 
data are shown as bar graphs. *P < 0.05 compared to respective V; aP < 0.05 compared to respective V; bP < 0.05 
compared to respective G0; d < 0.05 compared to respective G1; eP < 0.05 compared to respective G2.
Figure 8. VDA down regulates PAN-induced DPD expression of miR193a. (A) DPDs were transfected with 
either empty vector (EV) or miR193a inhibitor (plasmid, 25 nM), or treated with VDA (EB1089, 10 nM) in the 
presence or absence of PAN (30 ng/ml) for 48 hours (n = 3). RNAs were extracted and assayed for miR193a. 
Cumulative data are shown in bar graphs. *P < 0.05 compared with respective EV. **P < 0.01 compared with 
untreated EV; #P < 0.01 compared with PAN-treated EV. (B) DPDs were incubated in media containing either 
buffer (Control, C), vehicle (Veh, DMSO), or PAN (30 ng/ml) with or without VDA (EB1089, 10 nM) for 
48 hours (n = 3). Protein blots were probed for CD2AP, nephrin, APOL1, dynamin, and CTSL. The same blots 
were reprobed for GAPDH. Gels from three different lysates are shown. (C) The lysates in 8B were probed 
for dendrin (n = 3). Gels from three different lysates are displayed. (D) Cumulative densitometric data from 
the blots of 8B are shown in bar graphs. *P < 0.05 compared to respective C and Veh; **P < 0.05 compared 
to respective C and Veh; #P < 0.05 vs. PAN alone; ##P < 0.01 vs. PAN alone; ###P < 0.001 vs. PAN alone. (E) 
Cumulative densitometric data from the blots of 8C are shown in bar graphs. For clarity lanes were cropped 
from different gels. Full-length blots are presented in Fig. S8.
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To determine the effect of VDA on PAN-modulated ACs and associated downstream effects, DPDs were incu-
bated in media containing either vehicle (Veh, DMSO) or PAN (30 ng/ml) with or without VDA (EB1089, 10 nM) 
for 48 hours (n = 3). Protein blots were probed for CD2AP, nephrin, APOL1, dynamin, and CTSL. The same blots 
were reprobed for GAPDH. The same lysates were also probed for dendrin and GAPDH. Gels from three different 
cellular lysates are shown in Fig. 8B and C. Cumulative densitometric data are shown in bar graphs (Fig. 8D and E). 
PAN down-regulated the expression of nephrin, APOL1, dynamin, CD2AP, and dynamin but enhanced the 
expression of CTSL. These findings suggest that PAN destabilizes the complex. On the other hand, VDA protects 
against these effects of PAN.
Nuclear import of dendrin in podocytes in APOL1G1 transgenic mice. Four-week-old FVB/N, 
APOL1G0/G0, and APOL1G1/G1 transgenic mice (n = 4) were fed doxycycline in their feed for four weeks. 
Subsequently, kidneys were harvested, and renal cortical sections were labeled for nephrin, APOL1, and dendrin. 
Representative fluoromicrographs are shown in Fig. 9A. Podocytes of FVB/N mice showed cytosolic labeling for 
nephrin (purple fluorescence) and dendrin (green fluorescence). Tubular cells also showed labeling for dendrin. 
Podocytes in APOL1G0/G0 transgenic mice showed cytosolic labeling for APOL1 (red fluorescence), nephrin (pur-
ple fluorescence), and dendrin (green fluorescence). Tubular cells also showed labeling for APOL1 and dendrin. 
On the other hand, APOL1G1/G1 transgenic mice showed predominantly nuclear labeling for dendrin (green) in 
their podocytes. Dendrin partially co-labeled with DAPI (Fig. 9C) or nephrin (9D) were quantified using the Cell 
Profiler Program (Fig. 9B). These findings suggest that APOL1G1 induces nuclear import of dendrin in podocytes 
in vivo.
Albuminuria and glomerular sclerotic lesions in APOL1G1/G1 and APOL1G1/G2 mice. APOL1G0/G0 
mice did not show any increase in urinary albumin to creatinine ratio when compared to FVBN (28.57 ± 1.4 vs. 
APOL1G0/G0, 29.1 ± 1.2). APOL1G1/G1 (108.4 ± 24.3) and APOL1G1/G2 (116.9 ± 27.4) transgenic mice showed an 
increase (P < 0.01) in urinary albumin to creatinine ratio. However, only four out of seven (57%) of APOL1G1/G1 
and APOL1G1/G2 mice developed albuminuria (4-fold increase in albumin: creatinine ratio when compared to 
FVBN and APOL1G0/G0). Urinary albumin to creatinine ratio in each mouse is shown in Fig. 10A.
FVBN, APOL1G0/G0 and APOL1G1/G1 and APOL1G1/G2 mice with normal renal histology displayed normal uri-
nary albumin to creatinine ratio. APOL1G1/G1 and APOL1 G1/G2 transgenic mice with abnormal urine to creatinine 
ratio showed segmental solidification and sclerotic lesions in 15 to 18% of glomeruli. Representative micropho-
tographs are shown in Fig. 10B.
A proposed formulation to integrate these findings is schematically demonstrated in Fig. 11. Ectopic over-
expression of APOL1G0 in PDs down regulates miR193a expression resulting in an upregulation of WT1 and 
nephrin, which stabilizes the AC (Fig. 11A). The absence of nuclear dendrin decreases CTSL levels and thus 
prevents degradation of CD2AP, dynamin, and synaptopodin, the molecules which preserve the actin cytoskel-
eton in podocytes (Fig. 11A). On the other hand, DPDs expressing APOL1G1 and APOL1G2 are defective in 
down-regulation of miR193a, consequently resulting in attenuated expression of WT1 and nephrin that destabi-
lizes the ACs and enhances transcription of CTSL; the latter induces disorganization of the actin cytoskeleton in 
podocytes (Fig. 11B).
Discussion
In the present study, overt expression of APOL1G0 in podocytes, down-regulated the expression of miR193a 
indicating an intact APOL1 miR193a axis. The expression of APOL1G1 and G2 in DPDs was associated with 
upregulation of miR193a suggesting a disruption in APOL1-miR193a axis. DPDG0 showed a robust expres-
sion, but DPDG1s and DPDG2s displayed attenuated expression of the AC constituents. Enhanced expression 
of CTSL and down-regulation of dynamin expression also suggested the destabilization of the ACs in DPDG1s 
and DPDG2s. Downstream effects of the destabilized ACs manifested in the form of nuclear import of den-
drin and disorganization of the actin filaments in DPDG1s and DPDG2s. Since DPDs overexpressing miR193a 
also showed down-regulation of the AC constituents and upregulation of CTSL, it appears that disruption of 
APOL1-miR193a axis contributed to the destabilization of the ACs and disorganization of the actin filaments in 
DPDG1s and DPDG2s. In vivo studies, APOL1G1/G1 and APOL1G1/G2 transgenic mice exhibited nuclear import 
of dendrin, a consequence of destabilized ACs in podocytes. APOL1G1/G1 and APOL1G1/G2 transgenic mice 
also showed a four-fold increase in proteinuria when compared to control and APOL1G0/G0 transgenic mice. 
Renal histology revealed the development of segmental sclerotic lesions in 15–18% of glomeruli in APOL1 G1/
G1 and APOL1G1/G2 transgenic mice. PAN enhanced, but VDA inhibited the expression of miR193a in podo-
cytes in PAN-stimulated state. A miR193a inhibitor and VDA provided protection against APOL1 risk alleles- 
and PAN-induced down-regulation of the transcription of the AC constituents in podocytes. Since enhanced 
miR193a expression down-regulated nephrin expression, miR193a could have destabilized the ACs and disor-
ganized the actin cytoskeleton in adverse milieus as well as in mutant podocytes.
Interestingly, imaging studies in DPDG0s showed co-labeling of APOL1 and CD2AP at the adherent junc-
tions. Docking studies also showed binding of APOL1 to CD2AP; these findings suggest an interaction between 
APOL1 and CD2AP. However, the role of this interaction in the stabilization of the ACs is not clearly understood 
to date.
The net outcome of the silencing of APOL1 as well as of an overt expression of APOL1 risk alleles were similar 
i.e., increased transcription of the CTSL. Since APOL1 inversely regulates miR193a19, the lack of APOL1 would 
increase PD expression of miR193a. Also, overt expression of APOL1 risk alleles elevated miR193a levels in 
DPDs. In both the instances, miR193a would down-regulate the expression of nephrin resulting in destabilization 
of ACs and associated increased transcription of CTSL. Thus, it appears that expression of APOL1 risk alleles is 
equivalent to the loss of the function of APOL1G0 in podocytes.
1 1Scientific RepoRts |          (2019) 9:3582  | https://doi.org/10.1038/s41598-019-39376-y
www.nature.com/scientificreportswww.nature.com/scientificreports/
Interestingly, miR193a down-regulates APOL1 expression in podocytes19. Does an increase in miR193a 
expression represent an attempt to down-regulate APOL1 risk alleles by podocytes? In that scenario, 
miR193a-mediated toxicity would be considered as a gain of function by APOL1 risk alleles.
CD2AP and CTSL have been reported to have a feedback relationship in podocytes27. Podocyte injury 
down-regulates the expression of CD2AP culminating in the destabilization of the ACs and enhanced transcrip-
tion of CTSL27. The latter augments the degradation of CD2AP, which in turn would destabilize the ACs and 
result in the nuclear import of dendrin and associated transcription of CTSL. In the present study, enhanced 
expression of APOL1 contributed to an increased expression of CD2AP and a decreased expression of CTSL; 
Figure 9. Nuclear import of dendrin in podocytes in APOL1G1 transgenic mice. (A) Renal cortical sections 
of FVB/N, APOL1G0 (G0), and APOL1G1 (G1) transgenic mice (n = 4) were labeled for nephrin, APOL1, 
and dendrin. Representative microphotographs are displayed. Podocytes of an FVB/N mouse showed 
cytosolic labeling for nephrin (purple fluorescence) and dendrin (green fluorescence). Tubular cells also 
showed labeling for dendrin. Podocytes in an APOL1G0 transgenic mouse showed cytosolic labeling for 
APOL1 (red fluorescence), nephrin (purple fluorescence), and dendrin (green fluorescence). Tubular cells also 
showed labeling for APOL1 (red fluorescence). On the other hand, an APOLG1 transgenic mouse showed 
predominantly nuclear import of dendrin (green fluorescence, indicated by white arrows). Original Mag.X400. 
(B) A pipeline of modules of Broad Institute’s CellProfiler suite was used to analyze dendrin expression in 
podocytes. Representative original images of FVB/N, APOL1G0 and APOL1G1 glomeruli showing expression 
of nephrin (purple) dendrin (green) and DAPI (blue) were captured using Slidebook 6.0 software. Images were 
then processed using Cell Profiler pipeline to analyze expression of dendrin in cytosol and nucleus. Dendrin 
expressing pixels co-labeled with either nephrin or DAPI were measured and the total area occupied was 
calculated. Processed images are showing randomly denoted colors of the area occupied by pixels expressing 
dendrin and nephrin or dendrin and DAPI. Mag.X400. (C) Randomly selected glomeruli from FVB/N, 
APOL1G0 and APOL1G1 mice (Fig. 9B) were analyzed and data of the area occupied by pixels expressing 
dendrin and DAPI was collected. A bar graph is showing the number of pixels co-expressing dendrin and DAPI. 
(D) Randomly selected glomeruli from FVB/N, APOL1G0 and APOL1G1 mice (Fig. 9B) were analyzed and 
data of the area occupied by pixels expressing dendrin and nephrin was collected. A bar is showing the number 
of pixels co-expressing dendrin and nephrin.
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conversely, silencing of APOL1 in DPDs down-regulated the expression of CD2AP and enhanced the expression 
of CTSL. Therefore, our observations regarding CD2AP and CTSL relationship are consistent with the findings 
of the other investigators27.
Figure 10. Albumin to creatinine ratios and glomerular lesions in mice. (A) Four-week-old control (FVBN, 
n = 4) and transgenic mice (APOL1G0/G0, n = 3; APOL1G1/G1, n = 7); APOL1G1/G2, n = 7) were fed doxycycline in 
their feed. After six weeks urine was collected and albumin to creatinine ratio was assayed. Value of each mouse 
(urine sample) is shown in the dot plot. **P < 0.01 compared with FVBN/APOL1G0/G0. (B) A representative 
glomerulus from an FVBN mouse. Mag.X400. (C) A representative glomerulus from an APOL1G1/G1 mouse 
showing segmental solidification and expansion of the mesangial area with increased matrix and cellularity 
starting at the vascular pole and obliterated capillary space, findings consistent with FSGS. A focal adhesion of 
the capillary tuft is also present at about 2 o ’clock position. Mag.X400. (D) A representative glomerulus from an 
APOL1G1/G2 mouse showing a larger area of segmental solidification and expansion of the mesangium at 3 to 5 
o’ clock position compared to APOL1G1/G1 associated with obliterated capillary spaces, findings consistent with 
FSGS. A focal adhesion of the capillary tuft is also present at about 5 o ’clock position. Mag.X400.
Figure 11. Proposed hypothetical schemes. (A) APOL1G0 preserves actin cytoskeleton through down-regulation 
of miR193a and stimulation of nephrin expression, one of the constituents of the adherens complex. (B) APOL1G1 
and APOL1G2 disrupt APOL1-miR193a axis and induce upregulation of miR193a resulting down-regulation of 
WT1 and associated attenuated expression of nephrin, one of the constituents of the complex.
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In earlier studies, the loss of any of the components of the ACs led to the activation of the apoptotic path-
way24. These mechanistic studies served as the basis for the loss of glomerular filtration barrier in CD2AP and 
nephrin knockout mice. In our present study, silencing of nephrin also destabilized the ACs in podocytes. As 
expected, an elevation of miR193a in podocytes as a consequence of silencing of APOL1 or their mutation not 
only down-regulated nephrin expression but also destabilized the AC. Additionally, elevated miR193a levels (as 
a consequence of APOL1 silencing) could have down-regulated CD2AP expression through enhanced CTSL 
expression and exacerbation of autophagy33. Whether APOL1 silencing-induced loss of APOL1-CD2AP interac-
tion has affected the stability of the ACs independent of its effect on miR193a expression is not clear.
In the present study, PAN destabilized the ACs in DPDG0s. Since PAN enhanced miR193a expression, it 
appears that PAN could have destabilized the ACs through down-regulation of nephrin. Notably, VDA is known 
to down-regulate miR193a expression in PDs19,23. As expected, VDA provided protection against PAN-induced 
destabilization of the ACs and associated downstream effects through down-regulation of miR193a. These find-
ings indicate that down-regulation of miR193a plays an important role in the stabilization of the ACs. Therefore, 
this strategy could be used as a therapeutic tool to protect against podocyte injury induced by adverse milieus 
associated with elevated levels of miR193a.
We have earlier reported that overexpression of APOL1G1 and G2 induced lysosomal leakage of CTSL and 
interruption of the actin cytoskeleton in podocytes5. In those studies, we proposed the gain of function by APOL1 
risk alleles. The present study demonstrates that an optimal expression level of APOL1G0 maintains a low level 
of CTSL in the cytosol in PDs. It is conceivable in addition to pathways for a gain of function injury previously 
reported; there may also be a contribution to elevated cytosolic levels of CTSL and associated downstream effects 
in PDs expressing APOL1G1 and G2 due to a loss of function related to the maintenance of the ACs. The inter-
relation and the relative contribution of these mechanisms require further investigation and may also impinge 
on drug discovery strategies that target APOL1 risk alleles. Since organisms, which do not possess or express 
APOL1, seem to preserve the integrity of podocytes, this indicates that there are perhaps other mechanisms for 
the preservation of the complex. More specifically, podocyte ACs have been demonstrated to be functionally 
active in mice even though they lack APOL121,27. That suggests it is not the APOL1, but rather disruption in 
the APOL1-miR193a axis which is contributing to the destabilization of the ACs. The role of miR193a in the 
induction of injury in mouse podocytes has been demonstrated both in vitro and in vivo studies22. In vivo studies, 
miR193a transgenic mice demonstrated loss of WT1, nephrin, and CD2AP in podocytes22. These mice eventually 
developed focal segmental glomerulosclerosis. Thus, it appears that levels of miR193a have to be relatively lower 
to preserve podocyte molecular phenotype in mice.
The question arises if APOL1 is not required for the regulation of miR193a axis in the majority of the species, 
why have humans evolved APOL1 as a part of this axis? One explanation could be the shorter lifespan of mice 
and other species meaning thereby that they do not require highly specialized mechanisms for long-lived main-
tenance for terminally differentiated PDs. One may conjecture that the lack of APOL1 in mice could make them 
relatively more susceptible to podocyte injury. On the other hand, human beings are longer living mammals, 
requiring sustained longevity for terminal differentiated podocytes. To accomplish that goal, human PDs require 
extra safeguards for their protection. Nonetheless, the notion that evolution of APOL1 in human beings as a con-
stituent of miR193a axis to sustain longevity to PDs remains conjecture at present.
We conclude that an intact APOL1-miR193a axis plays an important role in the maintenance of the integrity 
of actin cytoskeleton, whereas, its disruption in podocytes expressing APOL1 risk alleles make them susceptible 
to disorganization of actin filaments.
Material and Methods
Human podocytes. Human podocytes (PDs) were conditionally immortalized by introducing tempera-
ture-sensitive SV40-T antigen by transfection34. DNA sequencing of these podocytes revealed the endogenous 
APOL1G0 genotype.
Generation of stable cell lines expressing APOL1G0/G1/G2 and Vector. Stable cell lines ectopically 
expressing APOL1G0, APOL1G1, and APOL1G2 were generated by retroviral infection in a different immortal-
ized undifferentiated human podocyte cell line as described previously15,19,35.
Undifferentiated PDs expressing vector (PDV) or ectopic APOL1G0/G1/G2 were seeded on collagen-coated 
plates and differentiated through incubation in normal RPMI (containing 11 mM glucose) for ten days at 37 °C 
(DPDVs, DPDG0s, DPDG1s, and DPDG2s). Since DPDG0s, DPDG1, and DPDG2 displayed unusually high 
expression of APOL1, the protein loading was decreased to reduce the expression; however, a decrease in protein 
loading minimized the APOL1 expression in DPDVs as described in our previous publication15.
Generation and Identification of APOL1G0/G0, APOL1G1/G1, and APOL1G1/G2 Transgenic Mice. 
The TetOn3G-APOL1G0 construct was released from the plasmid vector backbone by digestion with XhoI and 
purified by gel electrophoresis, and DNA was extracted using a QIAEX II Gel Extraction Kit (Qiagen). The puri-
fied DNA construct was introduced into the pronuclear of fertilized oocytes (from the FVB/N mouse) by micro-
injection using standard techniques. Details on characteristics of these mice have been described in our recent 
publication36. All experimental protocols were approved by the local committee for laboratory animal welfare 
of the Feinstein Institute for Medical Research, Manhasset, New York. All experiments were performed by the 
institutional guideline and regulations.
Urine Albumin: creatinine ratios and renal histology in control and APOL1 transgenic mice. 
Four-week-old control (FVBN, n = 4), APOL1G0/G0 (n = 3), APOL1G1/G1 (n = 7), and APOL1G1/G2 (n = 7) were 
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given doxycycline (200 mg/Kg) in their feed for six weeks. Subsequently, urine was collected, and kidneys were 
harvested. Albumin: creatinine ratio was assayed by an ELISA kit (Exocell Inc. Philadelphia). Renal cortical sec-
tions were stained with PAS. Ten glomeruli in each mouse were examined for the presence of glomerular sclerotic 
lesions.
Transfection of miR193a inhibitor. miR193a inhibitor (25 nM; Cat #4464084; Thermo Fisher) and 
empty vector (25 nM; pCMV-MIR; Origene) were transfected in the cells using Lipofectamine 3000 Transfection 
Reagent (Thermo Fisher) according to the manufacturer’s protocol.
Silencing of APOL1 and nephrin. DPDs were transfected with scrambled siRNA (control), APOL1 siRNA 
(20 nM; Santa Cruz), or nephrin siRNA (25 nM; Santa Cruz) with Lipofectamine RNAiMAX transfection reagent 
according to the manufacturer’s protocol (Thermo Fisher).
RNA isolation and qPCR studies. Real-Time PCR was performed using one-step iTaqTM Universal 
SYBR Green kit (BIO-RAD, USA) according to the manufacturer’s instructions using specific primers obtained 
from Thermo Fisher. GAPDH fw 5′ CCC ATC ACC ATC TTC CAG GAG 3′; rev 5′ GTT GTC ATG GAT GAC 
CTT GGC 3′, WT1 fw 5′ CGAGAGCGATAACCACACAACG 3′; rev 5′ GTCTCAGATGCCGACCGTACAA 
3′, CTSL fw 5′ GTTGCTATTGATGCAGGTCATGA 3′; rev 5′ ACTGCTACAGTCTGGCTCAAAATAAA ′3, 
APOL1 fw 5′ ATCTCAGCTGAAAGCGGTGAAC 3′; rev 5′ TGACTTTGCCCCCTCATGTAAG 3′, CD2AP fw 
5′ CTGTCAGCTGCAGAGAAGAAA 3′; rev 5′ TTGGGTTGGAGAATGTCCAC 3′. Quantitative PCR was per-
formed using an ABI Prism 7900HT sequence detection system and relative quantification of gene expression 
was calculated using the ΔΔCT method. Data were expressed as relative mRNA expression in reference to the 
control, normalized to the quantity of RNA input by performing measurements on an endogenous reference gene 
(GAPDH).
MicroRNA assay. For miRNA quantification, the total RNA was isolated from control and experimental 
DPDs and miR193a assayed as described in our recent publications19,36.
Immunofluorescence detection of F-actin and dynamin. Control and experimental podocytes were 
labeled for F-actin and dynamin as described in our previous publication37. In brief, cells were co-labeled with 
phalloidin (Alexa Fluor 568 #A12380; Thermo Fisher) and anti-dynamin antibody (mouse monoclonal; #sc-
17807, Santa Cruz Biotechnology). DAPI was used for nuclear localization. Control and experimental cells were 
examined under immunofluorescence microscope.
The cortical F-actin score (CFS) index was determined based on three independent experiments (100 cells). 
The F-actin cytoskeletal reorganization for each cell was scored on a scale ranging from 0 to 3 based on the degree 
of cortical F-actin ring formation (score = 0, no cortical F-actin, normal stress fibers; score = 1, cortical F-actin 
deposits below one-half of the cell border; score = 2, cortical F-actin deposits exceeding one-half of the cell bor-
der; score = 3, complete cortical ring formatting and/or total absence of central stress fibers)37.
Immunofluorescence of kidney tissue. Renal cortical sections from FVB/N (control), APOL1G0/G0 and 
APOL1G1/G1 transgenic mice were labeled with specific antibodies as described previously36,37. Primary antibod-
ies (nephrin,rabbit polyclonal, 1:100 dilution, #ab58968; Abcam; APOL1, mouse monoclonal, 1;100 dilution, 
#66124-1-lg, Proteintech; dendrin, rabbit polyclonal, 1:100 dilution, #ab204787, Abcam) were used followed by 
the fluorescent conjugated secondary antibody. Slides were examined by confocal microscopy.
Images of dendrin, nephrin, and DAPI staining were captured on the same Z-axis using Slidebook 6.0 soft-
ware. Image analysis and quantification were performed using Broad Institute’s (Cambridge, MA) CellProfiler 
suite38. Briefly, images were converted from the original color to gray and primary objects were identified as 20–60 
pixel objects in DAPI channel and 5–200 pixel objects for dendrin and nephrin channels. Identified objects of 
dendrin were masked with the objects identified for nephrin to determine dendrin objects labeled with nephrin. 
Identified objects of dendrin were also masked with the objects identified for DAPI to determine dendrin objects 
labeled with DAPI. Binary outlines were created and the area occupied by dendrin labeled with nephrin or the 
area occupied by dendrin labeled with DAPI was measured39. All measurements were exported directly to CSV 
files and were subsequently analyzed using Graph Pad Prizm to generate bar graphs.
Western blot studies. Western blot studies were carried out as described previously5,6,19,37. Primary anti-
bodies against APOL1 (mouse monoclonal, 1:1000 dilution, Proteintech), WT1 (rabbit polyclonal, 1:1000 dilu-
tion, Abcam, MA), nephrin (rabbit polyclonal #ab58968; Abcam), CD2AP (rabbit polyclonal; #sc-25272; Santa 
Cruz), CTSL (rabbit polyclonal; #sc10778; Santa Cruz), dendrin (rabbit polyclonal, 1:1000 dilution, abcam), 
and dynamin (mouse monoclonal; #sc-17807, Santa Cruz) were used followed by treatment with horseradish 
peroxidase-labeled appropriate secondary antibodies. Equal protein loading and the protein transfer were con-
firmed by immunoblotting for determination of actin/GAPDH protein using a  monoclonal  β-Actin/GAPDH 
antibody (Santa Cruz, CA) on the same (stripped) western blots.
Immunoprecipitation (IP). Lysates from control and experimental PDs were immunoprecipitated with 
either an anti-APOL1 (mouse monoclonal, Proteintech) - or an anti-CD2AP antibody (rabbit polyclonal; 
sc-25272, Santa Cruz). IP fractions were probed for different constituents of ACs as described previously19.
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Protein-protein Interaction prediction. By sequence similarity and domain interactions, the prediction 
of a protein-protein interaction of APOL1 and CD2AP was made. Sequence similarity between proteins depends 
on the alignments from the basic local alignment search tool (BLAST)40. Further, STRING server version 10.0 was 
used as the STRING database intends to present a critical assessment and integration of protein-protein interac-
tions, including direct (physical) as well as indirect (functional) alliances41.
Homology Modeling of APOL1 and CD2AP. We retrieved the sequence of human Apolipoprotein 1 
(APOL1) from the UniProt database (UniProt Id O14791). The sequence similarity with some of the templates 
was very low. Therefore, we selected two templates, i.e. c6ezvX (non-hemolytic enterotoxin lytic component l1) 
and c3gaab (protein from thermoplasma acidophilum) to model the APOL1 based on heuristics to maximize 
percentage identity, sequence coverage, and confidence using Phyre2 server42. Similarly, CD2AP (UniProt Id 
Q9Y5K6) was modeled using templates such as c2moxA (SH3 domain of sorbin and SH3 domain 2 containing 
protein 1) and c1griA (growth factor bound protein grb2).
3D modeling of miR193a. We retrieved the sequence of human miR193a-5p (miRBase Id = hsa-mir-
193a-5p) from the miRBase database43. The 3D model of miR193a was generated using RNAComposer server, 
which is a method based on machine translation principle and operates on the RNA-FRABASE database44.
Docking studies. Docking of APOL1G0 and CD2AP was performed using GRAMM-X web interface45 
that uses the FFT (Fast Fourier Transformation) methodology by utilizing the smoothed potentials, refinement 
stage, and knowledge-based scoring. The docking of APOL1G0 and miR193a was performed using NPDock that 
combines GRAMM program to perform a rigid body global search, ranking and scoring of best decoys using 
statistical potentials, and clustering of best decoys; finally, to optimize the protein-nucleic acid interactions in the 
representative clusters, a Monte Carlo Simulated Annealing procedure (with protein and nucleic acid molecules 
treated as rigid bodies) was utilized46.
Protein-protein and miRNA-protein interaction studies. The analyses of Protein-protein 
and miRNA-protein interactions were performed using SPPIDER47 and PDBePISA32 and KFC248 servers. 
Visualization of PPI and miRNA-protein complexes was performed using PyMol49.
Statistical analyses. Statistical comparisons were performed with the Prism program using the Mann–
Whitney U test for nonparametric data and the unpaired t test for parametric data. A P value < 0.05 was consid-
ered statistically significant.
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